Cabinet clears Advent's acquisition of Suven Pharma for Rs 9,589 crore

The Indian government has approved a foreign direct investment (FDI) proposal worth Rs. 9,589 crore in Suven Pharmaceuticals Limited. Private equity firm Advent International will acquire a 50.1% stake in the company for Rs. 6,313 crore, with plans to launch an open offer for an additional 26%.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news